Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Trikafta
Pharma
Vertex's sales of Trikafta hit $8.9B thanks to label expansion
Vertex presented figures that show its CF drug combo, Trikafta, remains formidable as it raked in $2.33B in sales, bringing its 2023 haul to $8.9B.
Kevin Dunleavy
Feb 6, 2024 12:39pm
In 'historic' nod, UK signs off on Vertex, CRISPR's gene therapy
Nov 16, 2023 11:45am
NICE rejects cost effectiveness of Vertex's cystic fibrosis meds
Nov 6, 2023 2:42pm
Vertex's CEO scored a major pay bump in 2021
Apr 8, 2022 11:10am
Is the cost of Vertex's Trikafta hampering CF treatment?
Feb 14, 2022 11:46am
Vertex's Trikafta posted megablockbuster sales in 202
Jan 27, 2022 9:55am